Financial reports
10-Q
2023 Q1
Quarterly report
11 May 23
10-K/A
2022 FY
Annual report (amended)
28 Apr 23
10-K
2022 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
9 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
10-K
2021 FY
Annual report
15 Mar 22
10-Q
2021 Q3
Quarterly report
9 Nov 21
10-Q
2021 Q2
Quarterly report
10 Aug 21
10-Q
2021 Q1
Quarterly report
11 May 21
Current reports
8-K
Termination of a Material Definitive Agreement
8 Jun 23
8-K
January 2024 PDUFA date expected
18 May 23
8-K
Other Events
3 May 23
8-K
SNBL to Acquire Satsuma Pharmaceuticals
17 Apr 23
8-K
Satsuma Pharmaceuticals Reports Fourth Quarter and Full Year 2022
28 Mar 23
8-K
Other Events
16 Feb 23
8-K
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
20 Dec 22
8-K
Other Events
30 Nov 22
8-K
Satsuma Pharmaceuticals Announces Topline Results from SUMMIT Phase
14 Nov 22
8-K
Entry into a Material Definitive Agreement
3 Nov 22
Registration and prospectus
15-12G
Securities registration termination
20 Jun 23
25-NSE
Exchange delisting
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 23
POS AM
Prospectus update (post-effective amendment)
8 Jun 23
POS AM
Prospectus update (post-effective amendment)
8 Jun 23
SC 13E3/A
Going private transaction (amended)
8 Jun 23
SC TO-T/A
Third party tender offer statement (amended)
8 Jun 23
Other
EFFECT
Notice of effectiveness
9 Jun 23
EFFECT
Notice of effectiveness
9 Jun 23
EFFECT
Notice of effectiveness
9 Jun 23
CORRESP
Correspondence with SEC
24 May 23
UPLOAD
Letter from SEC
23 May 23
UPLOAD
Letter from SEC
23 May 23
EFFECT
Notice of effectiveness
8 Nov 22
CORRESP
Correspondence with SEC
3 Nov 22
UPLOAD
Letter from SEC
3 Nov 22
EFFECT
Notice of effectiveness
3 May 21
Ownership
SC 13G/A
BML Investment Partners, L.P.
13 Jun 23
4
Peter Kolchinsky
12 Jun 23
SC 13D/A
RA CAPITAL MANAGEMENT, L.P.
12 Jun 23
4
Thomas P. O'Neil
8 Jun 23
4
Rajeev M. Shah
8 Jun 23
4
KEN TAKANASHI
8 Jun 23
4
Michael T Riebe
8 Jun 23
4
Elisabeth Sandoval
8 Jun 23
4
Thomas P Soloway
8 Jun 23
4
John A Kollins
8 Jun 23